Ignacio Handal, Clinicom

Note to File

Ignacio Handal is the CEO at Clinicom Healthcare. Ignacio has completed a multitude of FDA phase I, II, & III studies in pharmaceuticals, and devices over two decades. In 2022 Ignacio was honored with one of the highest honors in Clinical Research, the Christine Pierre Clinical trials lifetime achievement award of which only 8 clinical researchers globally have ever been awarded.

Early in his career Ignacio, Co-Founded the 5th leading private CNS research site in the US called Harmonex Neuroscience research in 2003 that continues excelling to this day.

Ignacio and his team have used 100% of the profits of their research trials over the last twenty years to develop the world's first online mental health assessment software that can assess anyone remotely for 81 mental health conditions in one virtual adaptive ML assessment. Clinicom has helped patients all over the world find answers on their mental health journey. Clinicom has also helped accelerate enrollment and patient identification for precise inclusion and exclusion criteria in 70 phase II and III studies in the US. The Clinicom mission is to give every patient a voice and to bring equity and access to mental health. Clinicom currently serves patients on 6 continents.

This week we discuss how to improve site selection, the challenges of vendor selection, and how Clinicom was born from a site.

Ignacio Handal on LinkedIn: https://www.linkedin.com/in/iggyhandal/

Clinicom on the web: www.clinicom.com/overview

Learn more about our sponsor, Veeva Vault: http://sites.veeva.com

Learn more about our sponsor, Inato: https://go.inato.com/41YxjXY